Overview Early Phase 2 Clinical Study of TS-142 in Patients With Insomnia Disorder Status: Completed Trial end date: 2019-02-13 Target enrollment: Participant gender: Summary Multicenter, randomized, placebo-controlled, 4-arm, 4-period crossover double-blind comparative study. Phase: Phase 2 Details Lead Sponsor: Taisho Pharmaceutical Co., Ltd.